176 related articles for article (PubMed ID: 8552628)
1. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.
Unson CG; Cypess AM; Wu CR; Goldsmith PK; Merrifield RB; Sakmar TP
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):310-5. PubMed ID: 8552628
[TBL] [Abstract][Full Text] [Related]
2. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
[TBL] [Abstract][Full Text] [Related]
3. Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding.
Unson CG; Cypess AM; Kim HN; Goldsmith PK; Carruthers CJ; Merrifield RB; Sakmar TP
J Biol Chem; 1995 Nov; 270(46):27720-7. PubMed ID: 7499239
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding.
Carruthers CJ; Unson CG; Kim HN; Sakmar TP
J Biol Chem; 1994 Nov; 269(46):29321-8. PubMed ID: 7961903
[TBL] [Abstract][Full Text] [Related]
5. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
7. Human glucagon receptor monoclonal antibodies: antagonism of glucagon action and use in receptor characterization.
Buggy J; Rossomando A; MacDougall M; Mierz D; Wunderlich D; Yoo-Warren H
Horm Metab Res; 1996 May; 28(5):215-9. PubMed ID: 8738108
[TBL] [Abstract][Full Text] [Related]
8. Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.
Hjorth SA; Adelhorst K; Pedersen BB; Kirk O; Schwartz TW
J Biol Chem; 1994 Dec; 269(48):30121-4. PubMed ID: 7527026
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
11. Positively charged residues at positions 12, 17, and 18 of glucagon ensure maximum biological potency.
Unson CG; Wu CR; Cheung CP; Merrifield RB
J Biol Chem; 1998 Apr; 273(17):10308-12. PubMed ID: 9553084
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of polyclonal antibodies raised against the N-terminus region (residues 9-30) of the follicle-stimulating hormone (FSH) receptor: significance of this receptor region in FSH recognition and signal transduction.
Dattatreyamurty B; Reichert LE
Endocrinology; 1993 Oct; 133(4):1593-601. PubMed ID: 8404599
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of a human glucagon receptor.
MacNeil DJ; Occi JL; Hey PJ; Strader CD; Graziano MP
Biochem Biophys Res Commun; 1994 Jan; 198(1):328-34. PubMed ID: 7507321
[TBL] [Abstract][Full Text] [Related]
14. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
15. Identification of an essential serine residue in glucagon: implication for an active site triad.
Unson CG; Merrifield RB
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):454-8. PubMed ID: 8290548
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
[TBL] [Abstract][Full Text] [Related]
17. The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.
Takhar S; Gyomorey S; Su RC; Mathi SK; Li X; Wheeler MB
Endocrinology; 1996 May; 137(5):2175-8. PubMed ID: 8612565
[TBL] [Abstract][Full Text] [Related]
18. Identification of glucagon receptors in rat brain.
Hoosein NM; Gurd RS
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4368-72. PubMed ID: 6087321
[TBL] [Abstract][Full Text] [Related]
19. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
